Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Parkview Health Builds Mirro Center for Research and Education
Parkview Health is building the $20 million Mirro Center for Research and Education in Fort Wayne, Ind. The 82,000-sf translational research facility will accommodate clinical trials for pharmaceutical products and medical devices, as well as housing instructional space and a simulation training suite. The building will provide labs, offices, conference rooms, and an auditorium. Completion is expected in early 2015.
NASA Opens Mission Integration Center
NASA Glenn Research Center opened the $20.5 million Mission Integration Center in Cleveland in July of 2014. The three-story, 90,000-sf facility provides collaborative research and office space to accommodate 300 employees. The project has attained LEED Gold sustainable design certification and will use 30 percent less energy and 40 percent less water than a conventional building. Construction began on the facility in September of 2010.
Kansas State University Breaks Ground on Bulk Solids Innovation Center
Kansas State University broke ground in July of 2014 on the Bulk Solids Innovation Center in Salina. Designed by Jones Gillam Renz Architects, the 130,000-sf facility will be the only research hub in North America for the study of bulk solids materials handling. The center is being built by Ron Fowles Construction and occupancy is expected in April of 2015.
WIRB-Copernicus Aquires Alliance Biosciences
WIRB-Copernicus Group (WCG), a global provider of regulatory and ethical review services for clinical research, acquired Alliance Biosciences in July of 2014. With this addition, WCG Biosafety will be able to manage the entire continuum of biocontainment oversight, helping to ensure that research involving potentially hazardous agents and vectors complies with the appropriate regulatory requirements from laboratory design and drug discovery through clinical testing and therapeutic application.
Merck Constructs Shanghai Pharmaceutical Plant
Merck will begin construction in August of 2014 on a 430,000-sf pharmaceutical production plant in Shanghai. The $107 million facility will manufacture drugs for diabetes as well as thyroid and heart conditions. Completion is expected in 2016 and commercial production will begin in 2017.